Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.

NCT01498679 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

311

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: GW685698/GW642444 (fluticasone furoate/vilanterol trifenatate)
DRUG: Placebo

Sponsor

GlaxoSmithKline